Tempus and Predicta partner on blood cancer genome testing assay

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. INTC
2. SPCX
3. DSX
4. GNK
5. DAL
6. AWK
7. MDA
8. ACN
9. III
10. SAN

Go back to Tempus and Predicta partner on blood cancer genome testing assay
StemCells, Inc. (NASDAQ: TEM) Delayed: 50.84 +2.05 (4.20%)
Previous Close $48.79    52 Week High $0.45 
Open $49.85    52 Week Low $0.37 
Day High $51.02    P/E N/A 
Day Low $48.85    EPS $-0.31 
Volume 5,925,872